about
Topiramate for the prophylaxis of episodic migraine in adultsAnticonvulsant drugs for migraine prophylaxisRandomized, placebo-controlled trial of propranolol added to topiramate in chronic migrainePreventive pharmacologic treatments for episodic migraine in adultsAnticonvulsant drugs for migraine prophylaxisEvidence-Based Treatments for Adults with MigraineCase reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière's disease or migraine-associated vertigo?Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraineChronic migraine--classification, characteristics and treatment.Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Clinical pharmacology of topiramate in migraine prevention.The prophylactic treatment of chronic daily headache.Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.The importance of placebo in headache research.Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trialA pilot study of topiramate dosages for migraine prophylaxis in an Asian population.New drugs for migraineThe pharmacotherapy of chronic pain: a review.Botulinum toxin type A for the treatment of migraine.Management of medication-overuse headache.Optimizing prophylactic treatment of migraine: Subtypes and patient matching.How clinicians can detect, prevent and treat medication overuse headache.Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.Topiramate in migraine progression.Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders.Treatment of chronic migraine.Latin American consensus on guidelines for chronic migraine treatment.Efficacy and mechanism of anticonvulsant drugs in migraine.Sodium channel antagonists for the treatment of migraine.Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society.Glutamate receptor antagonists in the management of migraine.Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.Chronic migraine: risk factors, mechanisms and treatment.Treatment Update of Chronic Migraine.Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
P2860
Q24201849-B400DD66-F6E2-422A-9E3A-EE42FF6A14E3Q24246734-D54B85FB-E344-45F3-9520-47B0FD892603Q24611845-96763F16-1078-48E0-86B1-79EF870F15BEQ24630992-272EF526-7B7A-42E5-939D-449119625754Q26471986-3642615A-DC68-46FB-B347-FC4829CF7853Q26769968-C58AE7F1-BD64-4019-9033-6AADC505B982Q30477512-E7B0645F-EC68-4716-83D7-EB1298E5C553Q33572495-2F740047-6FED-4914-8623-22D2E1B460EDQ34030691-5087F643-DF25-47C6-AF70-E7C523589157Q34180705-85FA431C-6A7F-4090-A140-546526BDD8A5Q34200361-2749C027-5CB8-4C30-8137-72F11E188D58Q34583067-1235B157-20D8-4841-A014-0154A56DB2D2Q34619560-F30617F1-F0B8-452D-813D-73E9D50D32FFQ34813721-858EA93A-1328-43E1-B448-1CB852511ACEQ35680421-C998337A-0EB5-49F8-A9E8-7F37E38883B5Q35690766-E4495AAE-B2EA-4A7F-9644-B87388766CFFQ35833247-63B3AAB5-F203-4CDE-95F1-24EBD66784D9Q36261182-303AB1E7-7003-4E42-9115-29F049E2D129Q36332611-3E2F4FE4-0CE2-433C-A446-679E067090C8Q36411163-E9F54058-EA1F-4DA2-AF9E-10D0003D701FQ36488226-954051F0-24F1-43D4-8B45-98CEB07CE7EEQ36941902-5E99EA61-8E8A-439D-87D7-363A616ACF8DQ37052803-2D085315-B57E-4B6E-96BB-0F08B4A6B716Q37317164-977AA291-43CC-4B76-B5B1-D5487B0606A6Q37593181-44BAB745-8E2F-48F9-99DD-346D76514798Q37617133-E1C0ACBD-8FFF-4A16-992D-4C983974EFE6Q37722781-39FA85BB-9425-4A65-8D20-AB414A139A11Q37724363-BC0973C4-EB93-4392-81DF-B15451F1E122Q37809775-69C0954D-3DB9-4B02-A696-7ED2912A0EC2Q38121835-66CC17EF-19E5-456E-A341-68755B75685BQ38185096-7AD2BF55-8022-4086-B771-8FA626AE65B2Q38221187-008BBAAB-CEE7-4DA1-A5B3-08ACF5695487Q38223491-0B7B8DC8-AF37-4639-8548-B88B76AC45BEQ38230246-B36ADC43-A711-45E8-969D-63DB2DE32C84Q38255772-863D9840-ECC3-4ADA-A6EC-15CB96D1D44AQ38569170-F4D2BB94-BFF1-4AAA-ADD2-599A91644840Q38773592-1E611D09-BCE6-42B8-88D9-56CACF041A5EQ38889450-A890DB28-8BBC-421F-9647-9DF8A986D094Q39251409-B9B09710-8181-4C4F-8691-22353C014A53Q39256375-8A6D7A02-0F96-4626-BD87-D1EF0A1A38E5
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Topiramate in the treatment of chronic migraine.
@en
Topiramate in the treatment of chronic migraine.
@nl
type
label
Topiramate in the treatment of chronic migraine.
@en
Topiramate in the treatment of chronic migraine.
@nl
prefLabel
Topiramate in the treatment of chronic migraine.
@en
Topiramate in the treatment of chronic migraine.
@nl
P2093
P2860
P1433
P1476
Topiramate in the treatment of chronic migraine.
@en
P2093
L Provinciali
M Bartolini
M Silvestrini
R Baruffaldi
P2860
P304
P356
10.1046/J.1468-2982.2003.00592.X
P407
P577
2003-10-01T00:00:00Z